Is RTCB a Potential Target for Pancreatic Cancer?
Knowledge@UChicago (University of Chicago) · 01.01.2026
DOI: 10.6082/uchicago.16914 ↗Kurz gefasst
Fachartikel in der Zeitschrift Knowledge@UChicago (University of Chicago), erschienen am 01.01.2026. Verfasst von Jennifer Hu und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Pancreatic neuroendocrine tumors (PanNETs) are a rare and aggressive form of pancreatic cancer that are often understudied and have few effective treatment options. One reason is limited understanding of the processes that enable these tumors to survive and grow under stress. Previous work in my lab has shown that a protein called RTCB is essential for PanNET cell growth, as removing RTCB consistently causes decreased proliferation. RTCB is known to play a critical role in the unfolded protein response involving XBP1, and it helps produce mature (intronless) tRNAs, both of which are fundamental to cellular stress adaptation and protein homeostasis. However, my lab has shown that restoring XBP1 alone is not enough to rescue cell growth, leaving open the question of which RTCB-dependent process is sufficient for PanNET survival. The goal of this project is to test whether impaired tRNA maturation fully accounts for the growth defects observed when RTCB is lost. To address this question, intronless tRNA sequences are cloned into a validated expression plasmid, allowing RTCB-deficient PanNET cells to overexpress mature tRNAs. These constructs are optimized and validated using northern blotting, and cell proliferation assays are used to determine whether restoring tRNA levels rescues growth. In parallel, we are developing a controllable RTCB knockout system in which cells retain a modified, degradable version of RTCB after the endogenous version is knocked out, allowing us to trigger complete RTCB loss at a chosen time to avoid rapid cell death. We anticipate that restoring mature tRNA levels will rescue growth in RTCB-knockout cells, supporting a central role for tRNA maturation in PanNET survival. By clarifying which RNA-processing functions of RTCB are sufficient for tumor growth, this work will improve understanding of stress adaptation in PanNETs and help inform future efforts to develop more targeted treatments for this understudied cancer type.
Schlagwörter
Zitieren
APA
Hu, J., Malnassy, G., Rosen, E., Rodriguez, L., Yang, J., Haynes, C. A., Dickinson, B. C., & Oakes, S. A. (2026). Is RTCB a Potential Target for Pancreatic Cancer?. Knowledge@UChicago (University of Chicago). https://doi.org/10.6082/uchicago.16914
Vancouver
Hu J, Malnassy G, Rosen E, Rodriguez L, Yang J, Haynes CA, et al. Is RTCB a Potential Target for Pancreatic Cancer?. Knowledge@UChicago (University of Chicago). 2026. doi:10.6082/uchicago.16914
BibTeX
@article{Hu2026,
author = {Hu, Jennifer and Malnassy, Gregory and Rosen, Eliza and Rodriguez, Lucia and Yang, Jingzhou and Haynes, Cassandra A. and Dickinson, Bryan C. and Oakes, Scott A.},
title = {Is RTCB a Potential Target for Pancreatic Cancer?},
journal = {Knowledge@UChicago (University of Chicago)},
year = {2026},
doi = {10.6082/uchicago.16914}
}
EUVIMED